Clinical InvestigationPrevention and RehabilitationQuantitative electrocardiographic measures and long-term mortality in exercise test patients with clinically normal resting electrocardiograms
Section snippets
Study population
We performed a single-center (Cleveland Clinic, Cleveland, OH) cohort study. Between September 1990 and December 2002, 46,966 patients without known CVD or end-stage renal disease, 30 years or older, were referred for symptom-limited treadmill exercise stress testing at our institution (Figure 1). None of the patients had known coronary disease (as defined by a history of myocardial infarction, percutaneous coronary intervention, or coronary artery bypass grafting), heart failure, documented
Patient characteristics
There were 18,964 patients with both a qualitatively normal ECG and a digital 12-lead resting ECG file available for quantitative analysis; their characteristics are shown in Table I.
Among these 18,964 patients, 3,441 (18%) were on aspirin, 1,178 (6%) were on statins, 217 (1%) were on other antihypelipidemic medications, 1,529 (8%) were on thiazide diuretics, 1,968 (10%) were on β-blockers, 1,635 (9%) were on calcium-channel blockers, and 1,447 (8%) were on angiotensin-converting enzyme
Discussion
In this study of 18,964 patients without known CVD who were referred for exercise testing and who had a clinically normal resting ECG, we found that a number of digitally measured ECG findings reflective of heart rate, conduction, left ventricular mass, and repolarization were predictive of long-term mortality individually and as a composite. However, the increased risk associated with a composite ECG score led to a small change in the OOB c-index (4.8%), which suggested that adding information
Summary and conclusions
We found that the resting ECG done before exercise testing may provide incremental prognostic value beyond determining validity of ST-segment interpretation. Subtle ECG findings relating to heart rate, conduction, left ventricular mass, and repolarization portend a worse long-term prognosis but only modestly improve discrimination and clinical risk stratification for all-cause mortality.
References (40)
- et al.
Nonspecific electrocardiographic abnormality as a predictor of coronary heart disease: the Framingham Study
Am Heart J
(1987) - et al.
Silent ST-T changes in an epidemiologic cohort study—a marker of hypertension or coronary heart disease, or both: the Reykjavik study
J Am Coll Cardiol
(1996) - et al.
The predictive value of resting electrocardiograms for 12-year incidence of coronary heart disease in the Honolulu Heart Program
J Clin Epidemiol
(1988) - et al.
QRS duration and mortality in patients with congestive heart failure
Am Heart J
(2002) - et al.
Long-term prognostic significance of isolated minor electrocardiographic T-wave abnormalities in middle-aged men free of clinical cardiovascular disease (The Multiple Risk Factor Intervention Trial [MRFIT])
Am J Cardiol
(2002) - et al.
Usefulness of exercise-induced ST-segment depression in the inferior leads during exercise testing as a marker for coronary artery disease
Am J Cardiol
(1992) - et al.
External prognostic validations and comparisons of age- and gender-adjusted exercise capacity predictions
J Am Coll Cardiol
(2007) - et al.
Cause of death in clinical research: time for a reassessment?
J Am Coll Cardiol
(1999) - et al.
Relative survival analysis in R
Comput Methods Programs Biomed
(2006) - et al.
Impact of minor electrocardiographic ST-segment and/or T-wave abnormalities on cardiovascular mortality during long-term follow-up
Am J Cardiol
(2003)